Probing the specificity of the bovine pituitary multicatalytic proteinase complex by inhibitors, activators, and by chemical modification
Affiliations
- PMID: 1801711
Item in Clipboard
Probing the specificity of the bovine pituitary multicatalytic proteinase complex by inhibitors, activators, and by chemical modification
Biomed Biochim Acta.
1991.
No abstract available
Similar articles
-
The multicatalytic proteinase (prosome, proteasome): comparison of the eukaryotic and archaebacterial enzyme.Biomed Biochim Acta. 1991;50(4-6):465-9. Biomed Biochim Acta. 1991. PMID: 1801710
-
Cleavage of Pro-X and Glu-X bonds catalyzed by the branched chain amino acid preferring activity of the bovine pituitary multicatalytic proteinase complex (20S proteasome).Arch Biochem Biophys. 1996 Oct 1;334(1):113-20. doi: 10.1006/abbi.1996.0436. Arch Biochem Biophys. 1996. PMID: 8837746
-
Components of the bovine pituitary multicatalytic proteinase complex (proteasome) cleaving bonds after hydrophobic residues.Biochemistry. 1999 Jul 27;38(30):9768-77. doi: 10.1021/bi990735k. Biochemistry. 1999. PMID: 10423257
-
Catalytic components of the bovine pituitary multicatalytic proteinase complex (proteasome).Enzyme Protein. 1993;47(4-6):296-305. doi: 10.1159/000468687. Enzyme Protein. 1993. PMID: 7697127 Review.
-
The multicatalytic proteinase complex.Revis Biol Celular. 1989;20:113-23. Revis Biol Celular. 1989. PMID: 2700095 Review.
Cited by
-
Proteasome inhibition: a new strategy in cancer treatment.Invest New Drugs. 2000 May;18(2):109-21. doi: 10.1023/a:1006321828515. Invest New Drugs. 2000. PMID: 10857991 Review.
-
Discovery and development of the anticancer agent salinosporamide A (NPI-0052).Bioorg Med Chem. 2009 Mar 15;17(6):2175-80. doi: 10.1016/j.bmc.2008.10.075. Epub 2008 Nov 5. Bioorg Med Chem. 2009. PMID: 19022674 Free PMC article.
-
Structure and structure formation of the 20S proteasome.Mol Biol Rep. 1997 Mar;24(1-2):103-12. doi: 10.1023/a:1006826725056. Mol Biol Rep. 1997. PMID: 9228290 Review.
-
Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.J Exp Med. 1999 Mar 15;189(6):895-906. doi: 10.1084/jem.189.6.895. J Exp Med. 1999. PMID: 10075973 Free PMC article.
-
The proteasome inhibitor epoxomicin has potent Plasmodium falciparum gametocytocidal activity.Antimicrob Agents Chemother. 2009 Oct;53(10):4080-5. doi: 10.1128/AAC.00088-09. Epub 2009 Aug 3. Antimicrob Agents Chemother. 2009. PMID: 19651911 Free PMC article.